Dr. Khoruts will explore ways the modern lifestyle has altered the human microbiome, and describe his work to create new therapeutic interventions to repair the invisible and unfolding ecological crisis within.
The Consortium conducts original research, serves students and faculty, and advances public dialogue and understanding on emerging issues at the intersection of science and society.
The Center for Bioethics is hosting a discussion on how ethics inform issues relating to health care across Africa. Three experts engaged in health care and research in different regions of Africa will discuss how ethics influences their work and how their work raises new questions about what ethics means, for whom, and why. Speakers are Rajesh Panjabi, MD, MPH (Last Mile Health; Harvard Medical School; Brigham and Women's Hospital), Siri Suh, MPH, PhD (Dept. of Gender, Women, and Sexuality Studies; Institute for Global Studies, University of Minnesota), and Michael Westerhaus, MD (School of Medicine; Center for International Health, University of Minnesota). The event will be held on Friday, Feb. 26 in 2-101 Nils Hasselmo Hall, and is free and open to the public.
New research led by Dr. Maria Gloria Dominguez-Bello indicates a promising new therapy for babies born by c-section. Cesarean infants typically have less diverse microbiomes when compared to babies born vaginally, a factor associated with increased risk for immune and metabolic disorders. In the study, described in Nature Medicine, infants delivered by c-section were swabbed with their mothers' vaginal fluids immediately upon being born. Subsequently, the gut, oral and skin bacterial communities of these babies was enriched and more closely resembled those who were delivered vaginally. Dr. Alexander Khoruts, MD, of the University of Minnesota's Microbiota Therapeutics Program, discussed the research and its implications in an article also published in Nature Medicine. On Wednesday, Feb. 17, Dr. Khoruts will be lecturing on Dr. Gloria Dominguez-Bello's research, his own pioneering therapeutic interventions, and the threat of antibiotic-resistant rogue superbugs.
The Office of the Vice President for Research (OVPR) has announced a Request for Proposals (RFP) to fund research infrastructure at the University of Minnesota. The effort is a part of the OVPR's mission of facilitating strong core facilities as the backbone for research excellence and to encourage cross disciplinary collaboration. The $4 million funding awarded to successful RFPs will be directed toward new or existing facilities, service centers or other shared resources across the university system. Matching funds are required. Read about deadlines, successful past RFPs and other information.
Registrations are now being taken for this year's Precision Medicine Conference. The event will focus on one of the most significant applications of precision medicine, identifying genes that predict response to medication and side effects. National experts in pharmacogenomics will present current considerations and applications of genomics; the status of precision medicine in the country; implementation in the clinical setting, including incorporation of data into EMR; and management of patients with these genetic variants, with an emphasis on psychiatry, cardiology and oncology. The first 150 conference registrants will have the opportunity to submit a DNA sample prior to the conference for their own personal pharmacogenomic panel with a lunchtime discussion on how these genotypes may affect their current and future medications. The public is welcome. Learn more and register.